Results 101 to 110 of about 37,585 (155)

Antithymocyte Globulin as Second-Line Therapy in Graves Orbitopathy-Preliminary Results From a Prospective Single-Center Study. [PDF]

Front Endocrinol (Lausanne), 2022
Sarnat-Kucharczyk M, Świerkot M, Handzlik G, Kulawik G, Jagoda K, Grochoła-Małecka I, Fryżewska J, Mrukwa-Kominek E, Chudek J.   +8 more
europepmc   +1 more source

Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 Pandemic. [PDF]

Ann Transplant, 2021
Kolonko A, Więcek A.
europepmc   +1 more source

Cytogenetic risk-associated outcomes of antithymocyte globulin use in HLA-matched sibling transplantation for acute myeloid leukemia. [PDF]

Ann Hematol
Kim M, Song IC, Ahn SY, Jang HC, Koh JS, Lee CH, Kim HJ, Yhim HY, Ahn JS.   +8 more
europepmc   +1 more source

Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry. [PDF]

Kidney Res Clin Pract, 2022
Lee JY, Kim SH, Park YH, Park JB, Lee SH, Yang J, Kim MS, Kim DG.   +7 more
europepmc   +1 more source

Modeling antithymocyte globulin-induced microvasculopathy using human iPSC-derived vascularized liver organoids. [PDF]

Cell Rep Med
Kawamura S, Yoneyama Y, Saiki N, Wu Y, Moriya C, Ohmura R, Maezawa M, Shimada Y, Wang Y, Mori K, Okada N, Onishi Y, Sanada Y, Hirata Y, Sakuma Y, Takebe T.   +15 more
europepmc   +1 more source

Graft-Versus-Host Disease Prophylaxis with Antithymocyte Globulin in Patients Receiving Stem Cell Transplantation from Unrelated Donors: An Observational Retrospective Single-Center Study. [PDF]

Cancers (Basel), 2023
Lo Schirico M, Passera R, Gill J, Dellacasa C, Dogliotti I, Giaccone L, Zompi S, Busca A.   +7 more
europepmc   +1 more source

Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient

Journal of Anaesthesiology Clinical Pharmacology, 2017
Shamim Rafat, Sahu Sandeep, Siddiqui Tasneem, Agarwal Sanjay   +3 more
doaj   +1 more source

Effective treatment of acute graft-versus-host disease following liver transplantation using an integrated regimen centered on antithymocyte globulin: a single-center experience. [PDF]

Front Immunol
Zheng Q, Zhang L, Wang H, Abdisamat A, Wang X, Xiao X, Jiang W.   +6 more
europepmc   +1 more source

The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation. [PDF]

PLoS One, 2021
Linhares K, Taddeo JB, Cristelli MP, Proença H, Ficher KN, de Marco R, Gerbase-DeLima M, Medina-Pestana J, Tedesco-Silva H.   +8 more
europepmc   +1 more source

Post-transplant cyclophosphamide improves survival compared to antithymocyte globulin in HLA-mismatched unrelated donor stem cell transplantation. [PDF]

Haematologica
Bordat J, Kaphan E, Robin M, Xhaard A, De Fontbrune FS, Chevillon F, Socie G, De Latour RP, Michonneau D.   +8 more
europepmc   +1 more source